Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA, Gadalla R, El-Ghonaimy EA, Samir O, Mohamed HT, Hassan H, Greve B, El-Shinawi M, Mohamed MM, Götte M
Research article (journal) | Peer reviewedDetails about the publication
Journal: Molecular Cancer
Volume: 16
Issue: 1
Status: Published
Release year: 2017 (05/03/2017)
Language in which the publication is written: English
Link to the full text: https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-017-0621-z
Keywords: Stammzellforschung; Tumorstammzellen; Extrazelluläre Matrix; Glykobiologie; Zellbiologie; Mammakarzinom; Onkologie
Authors from the University of Münster
| Götte, Martin |
Projects the publication originates from
Duration: 01/07/2015 - 30/06/2019 Funded by: EC H2020 - Marie Skłodowska-Curie Actions - Research and Innovation Staff Exchange Type of project: EU-project hosted at University of Münster |